Fig. 5.
ANG II (0.1 μM) greatly enhanced both basal (2.6-fold of control) and stimulated (2-fold of control) norepinephrine (NE) overflow from mesenteric bed preparations (n = 6) obtained from 10- to 12-wk-old SHRs in the presence of PD-123391 (AT2 receptor antagonist). **P < 0.01 compared with control.